The gene expression produce viral macrophage inflammatory protein-Ⅱ (vMIP-Ⅱ ) has been validated as anti-HIV medicine—entry inhibitor through competition combining chemokine receptors(CCR5/CXCR4).
基因表达产物病毒巨噬细胞炎症蛋白(viral macrophage inflammatory protein-Ⅱ,vMIP-Ⅱ)通过竞争性结合趋化因子受体(CCR5/CXCR4)作为抗HIV药物——进入抑制剂的作用已经得到证实。
参考来源 - 重组vMIP·2,447,543篇论文数据，部分数据来源于NoteExpress
Cautious optimism emerges with the release of the first entry inhibitor, Fuzeon.
人们怀着谨慎乐观的态度发行了第一个融合抑制剂——福泽昂。
A549 cells were pretreated with inhibitor of PLD(1- butanol), the invasion of A. fumigutas into host cells were detected to evaluate the role of PLD in A. fumigutas entry into host cells;
用不同浓度的PLD蛋白化学抑制剂（1-丁醇）预处理细胞，测定其对烟曲霉分生孢子侵染率的影响；
应用推荐